Showing 2571-2580 of 19323 results for "".
Challenging Migraine Stereotypes: Improving Patient Care Through Empathy and Insight
https://reachmd.com/programs/frontlines-migraine/challenging-migraine-stereotypes-improving-patient-care-through-empathy-and-insight/36154/Stigma and misconceptions around migraine can lead to misdiagnosis, undertreatment, and inequitable care, especially in emergency and primary care settings. Listening to patients, validating lived experiences, and enhancing clinical training to recognize migraine as a complex neurologic disorImproving Health Literacy to Empower Adolescents With Sickle Cell Disease
https://reachmd.com/programs/project-oncology/improving-health-literacy-to-empower-adolescents-with-sickle-cell-disease/35927/Health literacy directly influences outcomes for patients with sickle cell disease, especially during the critical transition from pediatric to adult care. Validated tools to help assess comprehension and simplified, patient-informed education materials are essential for optimal care. HearIdentifying CIDP: A Guide to Risk Profiles and Clinical Presentation
https://reachmd.com/programs/frontlines-cidp/identifying-cidp-a-guide-to-risk-profiles-and-clinical-presentation/33073/Early recognition of CIDP is essential to prevent irreversible damage and guide appropriate treatment, but its varied presentations can complicate diagnosis. Ryan Quigley sits down with Dr. Nicolas Dubuisson to discuss the clinical hallmarks of CIDP, its variants, and key risk factors. Dr. DubuissonInvestigating the Impact of Exercise on Cancer Immunotherapy Outcomes
https://reachmd.com/programs/project-oncology/investigating-the-impact-of-exercise-on-cancer-immunotherapy-outcomes/35680/Although immunotherapy has helped reshape cancer care, patient responses to this treatment approach vary widely. But according to a recent systematic review, exercise could play a role in enhancing immune function and outcomes during immunotherapy treatment. Learn more about the findings with Dr. SaFDA Grants Interchangeability to HADLIMA
https://reachmd.com/series/dermwire-tv/fda-grants-interchangeability-to-hadlima/35962/In this week's DermwireTV, the FDA grants full interchangeability to HADLIMA; new research shows the impact of UV exposure on global skin cancer cases; and coverage from Music City SCALE addresses barriers to patient access to new therapies.Predicting Immunotherapy Outcomes in Head and Neck Cancer: The Role of Genetic Signatures
https://reachmd.com/programs/project-oncology/predicting-immunotherapy-outcomes-in-head-and-neck-cancer-the-role-of-genetic-signatures/32998/Head and neck squamous cell carcinoma presents significant treatment challenges, like high mortality rates and limited predictive tools for immunotherapy success. That’s why a recent study examined genetic signatures that may help identify which patients will benefit from immunotherapy. To learn aboStratifying ICI-P Risk in Non-Small Cell Lung Cancer with Genetic and Radiographic Markers
https://reachmd.com/programs/project-oncology/stratifying-ici-p-risk-in-non-small-cell-lung-cancer-with-genetic-and-radiographic-markers/35659/New data from MD Anderson highlights a promising approach to predicting ICI-associated pneumonitis (ICI-P) in patients with NSCLC. Learn about how the findings could help personalize ICI therapy, reduce adverse outcomes, and improve clinical decision-making for at-risk patients. This research was prNail Disease and JAK Inhibitor Safety
https://reachmd.com/programs/practical-dermatology/nail-disease-and-jak-inhibitor-safety/35897/Brad Glick, DO, talks about the basics of nail anatomy, physiology, disease presentation, and treatments, as well as the safety of JAK inhibitors, at Music City SCALE 2025.The Subtle Threats of Benzene on Airway Health: Insights from an In Vitro ALI Model
https://reachmd.com/programs/clinicians-roundtable/the-subtle-threats-of-benzene-on-airway-health-insights-from-an-in-vitro-ali-model/35658/A recent study published in the American Journal of Respiratory and Critical Care Medicine found that sub-cytotoxic benzene exposure can disrupt oxidative stress signaling and immune cell chemotaxis in airway epithelial cells without activating typical inflammatory of metabolic pathways. Read aboutAdvancing Cancer Care: Key Considerations for Subcutaneous Immunotherapies
https://reachmd.com/programs/project-oncology/advancing-cancer-care-key-considerations-for-subcutaneous-immunotherapies/32995/Subcutaneous cancer immunotherapies may offer a faster, more resource-efficient alternative to intravenous administration, improving patient convenience and accessibility while maintaining efficacy. However, careful monitoring for immunotherapy-related toxicities remains essential. Joining Dr. Charl